| 000 | 01145 a2200337 4500 | ||
|---|---|---|---|
| 005 | 20250517204448.0 | ||
| 264 | 0 | _c20190626 | |
| 008 | 201906s 0 0 eng d | ||
| 022 | _a0028-2685 | ||
| 024 | 7 |
_a10.4149/neo_2018_170426N313 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aPalova, M | |
| 245 | 0 | 0 |
_aEffect of CALR and JAK2 mutations on the clinical and hematological phenotypes of the disease in patients with myelofibrosis - long-term experience from a single center. _h[electronic resource] |
| 260 |
_bNeoplasma _c |
||
| 300 |
_a296-303 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aCalreticulin _xgenetics |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aJanus Kinase 2 _xgenetics |
| 650 | 0 | 4 | _aMutation |
| 650 | 0 | 4 | _aPhenotype |
| 650 | 0 | 4 |
_aPrimary Myelofibrosis _xclassification |
| 700 | 1 | _aSzotkowski, T | |
| 700 | 1 | _aHlusi, A | |
| 700 | 1 | _aIndrak, K | |
| 700 | 1 | _aNavratilova, J | |
| 700 | 1 | _aDivoka, M | |
| 700 | 1 | _aPapajik, T | |
| 773 | 0 |
_tNeoplasma _gvol. 65 _gno. 2 _gp. 296-303 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.4149/neo_2018_170426N313 _zAvailable from publisher's website |
| 999 |
_c28174531 _d28174531 |
||